![Temporal Trends of Functional Outcome in Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis | Stroke Temporal Trends of Functional Outcome in Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis | Stroke](https://www.ahajournals.org/cms/asset/902ee3f3-30d4-4a60-933c-c0712a7e9c57/strokeaha.121.038400.fig04.jpg)
Temporal Trends of Functional Outcome in Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis | Stroke
![Planning After Stroke Survival: Advance Care Planning in the Stroke Clinic | Journal of the American Heart Association Planning After Stroke Survival: Advance Care Planning in the Stroke Clinic | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/80d0f717-c780-4818-b64b-c752dcb55b0c/jah34052-fig-0001.png)
Planning After Stroke Survival: Advance Care Planning in the Stroke Clinic | Journal of the American Heart Association
![Brain–kidney interaction: Renal dysfunction following ischemic stroke - Qiang Zhao, Tao Yan, Michael Chopp, Poornima Venkat, Jieli Chen, 2020 Brain–kidney interaction: Renal dysfunction following ischemic stroke - Qiang Zhao, Tao Yan, Michael Chopp, Poornima Venkat, Jieli Chen, 2020](https://journals.sagepub.com/cms/10.1177/0271678X19890931/asset/images/large/10.1177_0271678x19890931-fig2.jpeg)
Brain–kidney interaction: Renal dysfunction following ischemic stroke - Qiang Zhao, Tao Yan, Michael Chopp, Poornima Venkat, Jieli Chen, 2020
Full article: Gender differences in post-stroke depression: A longitudinal analysis of prevalence, persistence and predictive value of known risk factors
![Frontiers | Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases Frontiers | Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases](https://www.frontiersin.org/files/Articles/591065/fimmu-11-591065-HTML-r1/image_m/fimmu-11-591065-g001.jpg)
Frontiers | Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases
![Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy | Science Advances Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf9033/asset/13e74dba-9d3a-48f0-b96a-0905ee89efda/assets/graphic/abf9033-f1.jpeg)
Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy | Science Advances
![Sinus rhythm restoration and improved outcomes in patients with acute ischemic stroke and in-hospital paroxysmal atrial fibrillation - Dimitrios Sagris, Eleni Korompoki, George Ntaios, Stylianos Tzeis, Efstathios Manios, John Kanakakis, Haralampos ... Sinus rhythm restoration and improved outcomes in patients with acute ischemic stroke and in-hospital paroxysmal atrial fibrillation - Dimitrios Sagris, Eleni Korompoki, George Ntaios, Stylianos Tzeis, Efstathios Manios, John Kanakakis, Haralampos ...](https://journals.sagepub.com/cms/10.1177/23969873221109405/asset/images/large/10.1177_23969873221109405-img2.jpeg)
Sinus rhythm restoration and improved outcomes in patients with acute ischemic stroke and in-hospital paroxysmal atrial fibrillation - Dimitrios Sagris, Eleni Korompoki, George Ntaios, Stylianos Tzeis, Efstathios Manios, John Kanakakis, Haralampos ...
![Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial - The Lancet Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial - The Lancet](https://www.thelancet.com/cms/attachment/71d9b432-eaa0-4a68-a936-27d7eff14013/gr1.gif)
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial - The Lancet
![Frequency and features of embolic stroke of undetermined source in young adults - Kanjana S Perera, Balakumar Swaminathan, Roland Veltkamp, Antonio Arauz, Sebastian Ameriso, Joan Marti-Fabregas, Marcel Arnold, Graeme J Hankey, Helmi Frequency and features of embolic stroke of undetermined source in young adults - Kanjana S Perera, Balakumar Swaminathan, Roland Veltkamp, Antonio Arauz, Sebastian Ameriso, Joan Marti-Fabregas, Marcel Arnold, Graeme J Hankey, Helmi](https://journals.sagepub.com/cms/10.1177/2396987318755585/asset/images/large/10.1177_2396987318755585-fig1.jpeg)
Frequency and features of embolic stroke of undetermined source in young adults - Kanjana S Perera, Balakumar Swaminathan, Roland Veltkamp, Antonio Arauz, Sebastian Ameriso, Joan Marti-Fabregas, Marcel Arnold, Graeme J Hankey, Helmi
![IJMS | Free Full-Text | When Two Maladies Meet: Disease Burden and Pathophysiology of Stroke in Cancer IJMS | Free Full-Text | When Two Maladies Meet: Disease Burden and Pathophysiology of Stroke in Cancer](https://www.mdpi.com/ijms/ijms-23-15769/article_deploy/html/images/ijms-23-15769-g002.png)
IJMS | Free Full-Text | When Two Maladies Meet: Disease Burden and Pathophysiology of Stroke in Cancer
![Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial - The Lancet Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial - The Lancet](https://www.thelancet.com/cms/attachment/24bbb0e8-5b6b-4f40-8dbf-5baab03ce729/gr1_lrg.gif)
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial - The Lancet
![Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy | ACS Nano Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.1c02242/asset/images/medium/nn1c02242_0007.gif)
Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy | ACS Nano
![Brain–kidney interaction: Renal dysfunction following ischemic stroke - Qiang Zhao, Tao Yan, Michael Chopp, Poornima Venkat, Jieli Chen, 2020 Brain–kidney interaction: Renal dysfunction following ischemic stroke - Qiang Zhao, Tao Yan, Michael Chopp, Poornima Venkat, Jieli Chen, 2020](https://journals.sagepub.com/cms/10.1177/0271678X19890931/asset/images/large/10.1177_0271678x19890931-fig1.jpeg)
Brain–kidney interaction: Renal dysfunction following ischemic stroke - Qiang Zhao, Tao Yan, Michael Chopp, Poornima Venkat, Jieli Chen, 2020
![Posterior Stroke, EP Lead, HEAR Score, Ketamine for Suicidal Ideation, Peer Support Workers | EM Cases Posterior Stroke, EP Lead, HEAR Score, Ketamine for Suicidal Ideation, Peer Support Workers | EM Cases](https://emergencymedicinecases.com/wp-content/uploads/2022/07/Calgary-CARD.png)
Posterior Stroke, EP Lead, HEAR Score, Ketamine for Suicidal Ideation, Peer Support Workers | EM Cases
![Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial - The Lancet Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial - The Lancet](https://www.thelancet.com/cms/attachment/33ac2986-6354-48d0-b4e0-953f8193e7b1/gr1.gif)
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial - The Lancet
![Oleanolic, Ursolic, and Betulinic Acids as Food Supplements or Pharmaceutical Agents for Type 2 Diabetes: Promise or Illusion? | Journal of Agricultural and Food Chemistry Oleanolic, Ursolic, and Betulinic Acids as Food Supplements or Pharmaceutical Agents for Type 2 Diabetes: Promise or Illusion? | Journal of Agricultural and Food Chemistry](https://pubs.acs.org/cms/10.1021/acs.jafc.5b06021/asset/images/large/jf-2015-06021x_0003.jpeg)